Projecten per jaar
Persoonlijk profiel
Expertise
- Basic and translational research in multiple myeloma
- Research for therapies, targeting the myeloma cell in its microenvironment
- Study of functional interaction between the cancer cell and its microenvironment using microarray, realtime PCR and FACS analysis and westernblotting.
- Investigate the influence of histon deacetylase inhibitors (HDAC-I) in 5TMM models.
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Karin Vanderkerken actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 12 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landenniveau. Duik in de details door op de stippen te klikken.
Projecten
-
AIIFUND53: Targeting AXL, a putatieve dormancy regulatory in multiple myeloma.
De Veirman, K. & Vanderkerken, K.
10/01/20 → 31/12/21
Project: Fundamenteel
-
OZR3286: Bilateral cooperation within the framework of a joint doctoral project: Bench Fee for Joint PhD VUB-UGent, Vlummens Philip
13/02/18 → 31/12/22
Project: Fundamenteel
-
SRP48: Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)
Thielemans, K., Vanderkerken, K. & Breckpot, K.
1/11/17 → 31/10/22
Project: Fundamenteel
-
AIIFUND22: Een nieuwe strategie in het uitroeien van residuele kankercellen in multipel myeloom.
Vanderkerken, K. & De Veirman, K.
28/09/17 → …
Project: Fundamenteel
-
Onderzoeksoutput
-
A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma
Nylund, P., Atienza Párraga, A., Haglöf, J., De Bruyne, E., Menu, E., Garrido-Zabala, B., Ma, A., Jin, J., Öberg, F., Vanderkerken, K., Kalushkova, A. & Jernberg-Wiklund, H., 12 feb 2021, In : Cell & Death Disease. 12, 2, 16 blz., 167.Onderzoeksoutput: Article
-
Combining dual G9a/DNMTs epigenetic inhibition and immunotherapy to treat metastatic melanoma
De Beck, L., Awad, R. M., De Vlaeminck, Y., Basso, V., Casares, N., Verhulst, S., San José-Enériz, E., De Ridder, K., Goyvaerts, C., Maes, K., Vanderkerken, K., Agirre, X., Prosper, F., Lasarte, J. J., Mondino, A. & Breckpot, K., 2021, (Unpublished).Onderzoeksoutput: Unpublished abstract
-
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations
Rosiñol, L., Beksac, M., Zamagni, E., Van de Donk, N. W. C. J., Anderson, K. C., Badros, A., Caers, J., Cavo, M., Dimopoulos, M-A., Dispenzieri, A., Einsele, H., Engelhardt, M., Fernández de Larrea, C., Gahrton, G., Gay, F., Hájek, R., Hungria, V., Jurczyszyn, A., Kröger, N., Kyle, R. A. & 18 anderen, , 2021, In : British Journal of Haematology.Onderzoeksoutput: Article
-
AXL: A potential therapeutic target to eliminate cancer cells and improve chemotherapeutic responses in different hematological cancers
Vlummens, P., De Beule, N., Faict, S., Oudaert, I., Maes, K., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 14 feb 2020, In : Belgian Journal of Hematology. 11, O2, blz. 9-9 1 blz., 11.Onderzoeksoutput: Meeting abstract (Journal)
-
ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation
Zhang, D., De Veirman, K., Fan, R., Jian, Q., Zhang, Y., Lei, L., Evans, H., Wang, Y., Lei, L., Wang, B., Williamson, R. A., Chantry, A., He, P., Li, A., De Raeve, H., Vanderkerken, K., He, A. & Hu, J., dec 2020, In : Stem Cell Research & Therapy. 11, 1, 13 blz., 516.Onderzoeksoutput: Article
1 Citaat (Scopus)
Prijzen
-
Award of the Association for International Cancer Research
Karin Vanderkerken (Recipient), 2004
Prijs: Prize (including medals and awards)
-
Hilde Bruers Award
Karin Vanderkerken (Recipient), 29 feb 2008
Prijs: Prize (including medals and awards)
-
Junior Award Multiple Myeloma Research Foundation
Karin Vanderkerken (Recipient), 2001
Prijs: Prize (including medals and awards)
-
Laureaat Belgische Federatie tegen Kanker
Karin Vanderkerken (Recipient), 2001
Prijs: Prize (including medals and awards)
-
Laureaat Belgische Federatie tegen Kanker
Karin Vanderkerken (Recipient), 2004
Prijs: Prize (including medals and awards)
Activiteiten
-
MCL1 Inhibitors in Multiple Myeloma
Kim De Veirman (Contributor), Karin Vanderkerken (Speaker), Elke De Bruyne (Contributor), Eline Menu (Contributor)13 nov 2019Activiteit: Talk or presentation at a conference
-
Lunchdebat Gelijkheidsactieplan
Gina Rossi (Participant), Karin Vanderkerken (Participant)19 nov 2019Activiteit: Other
-
Epigen meeting
Karin Vanderkerken (Participant)27 feb 2014Activiteit: Participation in workshop, seminar
-
28th General Annual Meeting of the Belgian Hematological Society
Karin Vanderkerken (Participant)24 jan 2013 → 26 jan 2013Activiteit: Participation in conference
-
Multiple Myeloma and Related Malignancies, 2nd edition
Karin Vanderkerken (Keynote speaker)7 nov 2013 → 9 nov 2013Activiteit: Talk or presentation at a workshop/seminar
Knipsels
Scriptie
-
Anti-myeloom effect van histon deacetylase inhbitor LBH589 op het 5T33MM muismodel
Auteur: Lemaire, M., Vanderkerken, K. & Deleu, S., 1 jul 2007Begeleider: Vanderkerken, K. (Promotor) & Deleu, S. (Co-promotor)
Scriptie/masterproef: Master's Thesis
-
ASPIRE: adjuvant-driven induction of cancer Specific Immune Responses
Auteur: Van Der Jeught, K., Breckpot, K., Thielemans, K., Vanderkerken, K., Menu, E., van Grunsven, L. A., Pascolo, S. & Raemdonck, K., 20 okt 2016Begeleider: Breckpot, K. (Promotor), Thielemans, K. (Promotor), Vanderkerken, K. (Jury), Van Grunsven, L. A. (Jury), Menu, E. (Jury), Van Raemdonck, K. (Externe persoon) (Jury) & Pascolo, S. (Externe persoon) (Jury)
Scriptie/masterproef: Doctoral Thesis
-
Beta cell regeneration and normoglycemia restoration in diabetic mica through myeloid cell-driven angiogenesis
Auteur: Xiao, X., 6 jun 2011Begeleider: Heimberg, H. (Promotor), Dor, Y. (Externe persoon) (Jury), Haigh, J. (Externe persoon) (Jury), Luttun, A. (Externe persoon) (Jury), Vanderkerken, K. (Jury), Tournaye, H. (Jury), Van Riet, I. (Promotor) & Thielemans, K. (Promotor)
Scriptie/masterproef: Doctoral Thesis
-
Beta cell regeneration and normoglycemia restoration in diabetic mice through myeloid celldriven angiogenesis
Auteur: Xiao, X., Heimberg, H., Thielemans, K., Vanderkerken, K., Tournaye, H., Van Riet, I., Dor, Y., Haigh, J. & Luttun, A., 6 jun 2011Begeleider: Heimberg, H. (Promotor), Thielemans, K. (Jury), Vanderkerken, K. (Jury), Tournaye, H. (Jury), Van Riet, I. (Jury), Dor, Y. (Externe persoon) (Jury), Haigh, J. (Externe persoon) (Jury) & Luttun, A. (Externe persoon) (Jury)
Scriptie/masterproef: Doctoral Thesis
-
Biological and clinical implications of invariant natural killer T cells in multiple myeloma: rising the potential for immunotherapy
Auteur: Nur, H., Menu, E. & Vanderkerken, K., 17 sep 2014Begeleider: Menu, E. (Promotor) & Vanderkerken, K. (Promotor)
Scriptie/masterproef: Doctoral Thesis